CLICK HERE to view the AMA Episode.
In this AMA, IFBB Pro Morgan MacDonald breaks down what makes this triple agonist different from Ozempic and other GLP-1s—covering fat-burning benefits, insulin sensitivity, muscle loss risks, and real-world use for bodybuilders. Is it the future of fat loss…...